Methamphetamine-induced stereotypy correlates negatively with patch-enhanced prodynorphin and arc mRNA expression in the rat caudate putamen: The role of mu opioid receptor activation

Pharmacology Biochemistry and Behavior

Volumn 95, Issue 4, 2010, Pages 410-421

  Horner, Kristen A ^a   Noble, Erika S ^a   Gilbert, Yamiece E ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior; Caudate putamen; Immediate early gene; Opioid; Psychostimulant

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; GENE PRODUCT; MESSENGER RNA; METHAMPHETAMINE; MU OPIATE RECEPTOR; PRODYNORPHIN; PROTEIN ACR; PROTEIN ZIF; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HOMEOSTASIS; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; STEREOTYPY;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CYTOSKELETAL PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ENKEPHALINS; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION; MALE; METHAMPHETAMINE; NERVE TISSUE PROTEINS; NEURONS; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SOMATOSTATIN; STEREOTYPIC MOVEMENT DISORDER; TIME FACTORS;

ANIMALIA; RATTUS;

EID: 77952527003     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.02.019     Document Type: Article

References (54)

1. Adams A.C., Layer R.T., McCabe T., Keefe K.A. Effects of conanotoxins on L-3-4-dihydroxyphenylalanine-induced behavior and immediate early gene expression. Eur J Pharmacol 2000, 404:303-313.
2. Adams D.H., Hanson G.R., Keefe K.A. Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum. Neuroscience 2001, 102:843-851.
3. Adams D.H., Hanson G.R., Keefe K.A. Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix. J Neurochem 2003, 84:87-93.
4. Bolam J.P., Izzo P.N., Graybiel A.M. Cellular substrate of the histochemically defined striosome and matrix system of the caudate nucleus: a combined golgi and immunohistochemical study. Neuroscience 1988, 24:853-875.
5. Brami-Cherrier K., Valjent E., Hervé D., Darragh J., Corval J.-C., Pages C., Simon A.J., Girault J.-A., Caboche J. Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice. J Neurosci 2005, 25:11444-11454.
6. Canales J.J., Graybiel A.M. A measure of striatal function predicts motor stereotypy. Nat Neurosci 2000, 3:377-383.
7. Capper-Loup C., Canales J.J., Kadaba N., Graybiel A.M. Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J Neurosci 2002, 22:6216-6227.
8. Chavkin, C. Electrophysiology of opiates and opioid peptides. In: Pasternak, GW, editor. The Opiate Receptors. Clifton, N.J.: Humana Press, 1988.
9. Civelli O., Douglass J., Goldstein A., Herbert E. Sequence and expression of the rat dynorphin gene. Proc Natl Acad Sci USA 1985, 82:4291-4295.
10. Cole R.L., Konradi C., Douglass J., Hyman S.E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 1995, 14:813-823.
11. Creese I., Iverson S.D. Blockage of amphetamine-induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res 1973, 55:369-382.
12. Fosnaugh J.S., Bhat R.V., Yamagata K., Worley P.F., Baraban J.M. Activation of arc, a putatuve "effector" immediate early gene, by cocaine in rat brain. J Neurochem 1995, 64:2377-2380.
13. Frankel P.S., Hoonakker A.J., Danaceau J.P., Hanson G.R. Mechanism of an exaggerated locomotor response to a low-dose challenge of methamphetamine. Pharmacol Biochem Behav 2007, 86:511-515.
14. Gerfen C.R. The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 1984, 311:461-464.
15. Gerfen C.R. The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science 1989, 246:385-388.
16. Glickstein S.B., Schmauss C. Focused stereotypies do not require enhanced activation of neurons in striosomes. J Comp Neurol 2004, 469. 277-238.
17. Gonzalez-Nicolini M.V., Berglind W., Cole K.S., Keogh C., McGinty J.F. Local mu and delta opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum. Neuroscience 2003, 121:387-398.
18. Gonzalez-Nicolini V., McGinty J.F. Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization histochemical study. Gene Expression Patterns 2002, 1:193-198.
19. Graybiel A.M., Canales J.J. The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome. Adv Neurol 2000, 85:123-131.
20. Graybiel A.M., Canales J.J., Capper-Loup C. Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci 2000, 23:S71-S77.
21. Graybiel A.M., Rauch S.L. Toward a neurobiology of obsessive-compulsive disorder. Neuron 2000, 28:343-347.
22. Herkenham M., Pert C.B. Mosaic distibution of opiate receptors, parafascilular projections and acetylcholinesterase in rat striatum. Nature 1981, 291:415-418.
23. Horner K.A., Adams D.H., Hanson G.R., Keefe K.A. Blockade of stimulant-induced preprodynoprhin mRNA expression in the rat striatal matrix by serotonin depletion. Neuroscience 2005, 131:67-77.
24. Horner K.A., Keefe K.A. Regulation of psychostimulant-induced preprodynorphin, c-fos and zif/268 messenger RNA expression in the rat dorsal striatum by mu opioid receptor blockade. Eur J Pharmacol 2006, 532:61-73.
25. Horner K.A., Noble E.S., Lauterbach E.C. Differential regulation of prodynophin, c-fos, and serotonin transporter mRNA following withdrawal from a chronic, escalating dose regimen of d-amphetamine. Synapse 2009, 63:257-268.
26. Keefe K.A., Gerfen C.R. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonistss and antagonists on immediate early gene expression. Neuroscience 1995, 66:903-913.
27. Kramer T.H., Shook J.E., Kzamierski W., Ayres E.A., Wire W.S., Hruby V.J., Burks T.F. Novel peptidergic mu opioid antagonists: pharmacological characterization in vitro and in vivo. J Pharmacol Exp Ther 1988, 249:544-551.
28. LaHoste G.J., Yu J., Marshall J.F. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 1993, 90:7451-7455.
29. Lyford G., Yamagata K., Kaufmann W., Barnes C., Sanders L., Copeland N., Gilbert D., Jenkins N., Lanahan A., Worley P.F. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 1995, 14:433-445.
30. Margolis E.B., Hjelmstad G.O., Bonci A., Fields H.L. k-opioid agonists directly inhibit midbrain dopaminergic neurons. J Neurosci 2003, 23:9981-9986.
31. Meshul C.K., McGinty J.F. Kappa opioid receptor immunoreactivity in the nucleus accembens and caudate-putamen is primarily associated with synpatic vesicles in axons. Neuroscience 2000, 96:91-99.
32. Mildbrandt J.A. Nerve growth-factor-induced gene encodes a possible transcriptional regulatory factor. Science 1987, 248:797-799.
33. Moratalla R., Robertson H.A., Graybiel A.M. Dynamic regulation of NGFI-A (zif268, egr1) gene exprssion in the striatum. J Neurosci 1992, 12:2609-2622.
34. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse 1990, 6:106-112.
35. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier Academic Press, San Diego, CA.
36. Pert C.B., Kuhar M., Snyder S.H. Opiate receptor: autoradiographic localization in the rat brain. Proc Natl Acad Sci USA 1976, 73:3729-3733.
37. Presti M.E., Lewis M.H. Striatal opioid peptide content in an animal model of spontaneous stereotypic behavior. Behav Brain Res 2005, 157:363-368.
38. Ragsdale C.W., Graybiel A.M. Fibers from the basolateral amygdala selectively innervate the striosomes in the caudate nucleus of the cat. J Comp Neurol 1988, 269:506-522.
39. Schad C.A., Justice J.B., Holtzman S.G. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J Neurochem 1996, 67:2292-2299.
40. Shi X., McGinty J.F. Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience 2006, 138:1289-1298.
41. Shoda T., Fukuda K., Uga H., Mima H., Morikawa H. Activation of μ-opioid receptor induces expression of c-fos and junB via mitogen-activated protein kinase cascade. Anesthesiology 2001, 983-989.
42. Steward O., Wallace C.S., Lyford G., Worley P.F. Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 1998, 21:741-751.
43. Steward O., Worley P.F. Selective targeting of newly synthesized Arc mRNA to actived synapses requires NMDA receptor activation. Neuron 2001, 30:227-240.
44. Tan A., Moratalla R., Lyford G., Worley P.F., Graybiel A.M. The activity-regulated cytoskeletal-associated protein Arc is expressed in different striosome-matrix patterns following exposure to amphetamine and cocaine. J Neurochem 2000, 74:2074-2078.
45. Tempel A., Zukin R.S. Neuroanatomical patterns of the mu, delta and kappa opioid receptors of the rat brain as determined by quantitative in vitro autoradiography. Proc Natl Acad Sci USA 1987, 43:4308-4312.
46. Ujike H., Onoue T., Akiyama K., Hamamura T., Otsuki S. Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology 1989, 98:89-92.
47. Walker J.M., Thompson L.A., Frascella J., Friederich M.W. Opposite effects of mu and kappa opiate on the firing-rate of dopamine cell in the substantia nigra of the rat. Eur J Pharmacol 1987, 134:53-59.
48. Walker R.H., Arbuthnott G.W., Baughman R.W., Graybiel A.M. Dendritic domains of medium spiny neurons in the primate striatum: relationship to striosomal borders. J Comp Neurol 1993, 337:614-628.
49. Wang J.Q., McGinty J.F. Dose-dependent alterations in zif/268 and preprodynorphin mRNA exprsesion induced by amphetamine and methamphetamine in rat forebrain. J Pharmacol Exp Ther 1995, 273:909-917.
50. Wang J.Q., Smith A.J., McGinty J.F. A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin messenger RNA expression in the rat forebrain. Neuroscience 1995, 68:83-95.
51. Woo S.K., Hitzemann R.J., Loh H.H. Specific opioid-amphetamine interactions in the caudate putamen. Psychopharmacology 1985, 85:371-376.
52. Yin H.H., Knowlton B.J. The role of the basal ganglia in habit formation. Nat Rev Neurosci 2006, 7:464-476.
53. You Z.-B., Herrera-Marchitz M., Terenius L. Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides. J Pharmacol Exp Ther 1999, 290:1307-1315.
54. Ziółkowska B., Urbański M.J., Wawrzczak-Bargieła A., Bilecki W., Przewłocki R. Morphine activates Arc expression in the mouse striatum and in mouse neuroblastoma Neuro2A MOR1A cells expressing mu-opioid receptors. J Neurosci Res 2005, 82:563-570.